PHARMA 2424: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA 2424
Largest movements
- Cash -€69,181
down €69,181 (-49.5%), from €139,824 to €70,643
mainly Debts after one year (-€77,121) and Current investments (-€57,000)
- Current investments +€57,000
up €57,000 (+69.5%), from €82,000 to €139,000
- Intangible fixed assets -€37,800
down €37,800 (-33.3%), from €113,400 to €75,600
- Tangible fixed assets -€16,757
down €16,757 (-28.5%), from €58,880 to €42,123
of which Furniture and vehicles: -€11,064
- Debts after one year -€77,121
down €77,121 (-41.1%), from €187,842 to €110,721
- Reserves +€56,862
up €56,862 (+25.0%), from €227,740 to €284,601
- Other debts -€24,940
down €24,940 (-92.7%), from €26,913 to €1,973
- Current portion of long-term debt -€6,261
down €6,261 (-7.5%), from €83,381 to €77,121
- Financial charges -€3,135
down €3,135 (-35.1%), from €8,933 to €5,797
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €608,542 | €550,405 | -€58,137 | -9.6% |
| Fixed assets | 21/28 | €172,280 | €117,723 | -€54,557 | -31.7% |
| Intangible fixed assets | 21 | €113,400 | €75,600 | -€37,800 | -33.3% |
| Tangible fixed assets | 22/27 | €58,880 | €42,123 | -€16,757 | -28.5% |
| Plant, machinery and equipment | 23 | €36,989 | €31,295 | -€5,693 | -15.4% |
| Furniture and vehicles | 24 | €21,892 | €10,828 | -€11,064 | -50.5% |
| Current assets | 29/58 | €436,262 | €432,682 | -€3,580 | -0.8% |
| Stocks and contracts in progress | 3 | €143,975 | €146,827 | +€2,853 | +2.0% |
| Stocks | 30/36 | €143,975 | €146,827 | +€2,853 | +2.0% |
| Amounts receivable within one year | 40/41 | €64,662 | €70,504 | +€5,841 | +9.0% |
| Trade receivables | 40 | €64,662 | €70,504 | +€5,841 | +9.0% |
| Other amounts receivable | 41 | €0 | - | = | |
| Current investments | 50/53 | €82,000 | €139,000 | +€57,000 | +69.5% |
| Cash at bank and in hand | 54/58 | €139,824 | €70,643 | -€69,181 | -49.5% |
| Deferred charges and accrued income | 490/1 | €5,801 | €5,708 | -€93 | -1.6% |
| Total equity and liabilities | 10/49 | €608,542 | €550,405 | -€58,137 | -9.6% |
| Equity | 10/15 | €247,740 | €304,601 | +€56,862 | +23.0% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €227,740 | €284,601 | +€56,862 | +25.0% |
| Distributable reserves | 133 | €227,740 | €284,601 | +€56,862 | +25.0% |
| Amounts payable | 17/49 | €360,802 | €245,804 | -€114,999 | -31.9% |
| Amounts payable after more than one year | 17 | €187,842 | €110,721 | -€77,121 | -41.1% |
| Financial debts | 170/4 | €187,842 | €110,721 | -€77,121 | -41.1% |
| Amounts payable within one year | 42/48 | €169,965 | €134,158 | -€35,806 | -21.1% |
| Current portion of amounts payable after more than one year | 42 | €83,381 | €77,121 | -€6,261 | -7.5% |
| Trade debts | 44 | €38,532 | €36,825 | -€1,707 | -4.4% |
| Suppliers | 440/4 | €38,532 | €36,825 | -€1,707 | -4.4% |
| Taxes, remuneration and social security | 45 | €21,139 | €18,240 | -€2,898 | -13.7% |
| Taxes | 450/3 | €10,367 | €12,120 | +€1,753 | +16.9% |
| Remuneration and social security | 454/9 | €10,772 | €6,121 | -€4,651 | -43.2% |
| Other amounts payable | 47/48 | €26,913 | €1,973 | -€24,940 | -92.7% |
| Accrued charges and deferred income | 492/3 | €2,996 | €924 | -€2,072 | -69.2% |
| Remuneration, social security and pensions | 62 | €50,127 | €48,856 | -€1,272 | -2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €53,845 | €54,557 | +€712 | +1.3% |
| Other operating charges | 640/8 | €1,121 | €880 | -€241 | -21.5% |
| Gross operating margin | 9900 | €196,925 | €195,539 | -€1,386 | -0.7% |
| Operating profit (loss) | 9901 | €91,832 | €91,247 | -€585 | -0.6% |
| Financial income | 75/76B | €708 | €797 | +€89 | +12.6% |
| Recurring financial income | 75 | €708 | €797 | +€89 | +12.6% |
| Financial charges | 65/66B | €8,933 | €5,797 | -€3,135 | -35.1% |
| Recurring financial charges | 65 | €8,933 | €5,797 | -€3,135 | -35.1% |
| Profit (loss) for the period before taxes | 9903 | €83,607 | €86,246 | +€2,639 | +3.2% |
| Income taxes | 67/77 | €28,411 | €29,384 | +€973 | +3.4% |
| Profit (loss) for the period | 9904 | €55,196 | €56,862 | +€1,666 | +3.0% |
| Profit (loss) for the period to be appropriated | 9905 | €55,196 | €56,862 | +€1,666 | +3.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.